Open original FDA record ↗Recall record
- FDA identifier
- Z-2533-2024
- Company in FDA record
- Luminex Corporation
- FDA classification date
- Aug 8, 2024
- First observed by MedTech Watch
- Nov 16, 2026
- Latest observed content change
- Nov 16, 2026
- Recall classification
- Class II
Reason stated in the source
Potential for defective test cartridges which may result in false positive results for the Staphylococcus lugdunensis and Enterococcus faecium targets.
Source facts
- Action
- Diasorin sent a recall notification on 06/20/2024, via email. Consignees were instructed to examine inventory and quarantine any affected units, arrange for replacement and confirm disposal of any of affected units on hand. Customers were asked to perform a retrospective review of results for VERIGENE Gram-Positive Blood Culture Nucleic Acid Test (BC-GP) to look for any false positives, distribute the notification to any relevant personnel, notify consignees if further distributed and complete and return the "Acknowledgement & Receipt Form."
- Initiated
- 2024-06-20
- Root cause
- Under Investigation by firm
- Distribution
- US Nationwide distribution including in the states of AZ, CA, CO, DE, FL, GA, IA, IL, KY, MD, MI, MN, MO, MS, NE, NV, OH, OK, SC, TN, TX, VA, VT, WA, WV.
- Recall number
- Z-2533-2024
- Recall status
- Open, Classified
- CDRH record ID
- 208994
- FDA classified
- 2024-08-08
- Recall event number
- 94970